Abstract
Summary
This study reviewed the risk factors of Osteosarcopenic obesity (OSO), a condition linking weak bones, muscle loss, and obesity. Notable associations were found with female gender, physical inactivity, hypertension, and frailty. Recognizing these early can aid targeted prevention, emphasizing further research for improved understanding and strategies.
Purpose
Osteosarcopenic obesity (OSO) represents a confluence of osteopenia/osteoporosis, sarcopenia, and obesity, contributing to increased morbidity and mortality risks. Despite escalating prevalence, its risk factors remain under-explored, necessitating this comprehensive systematic review and meta-analysis.
Methods
A diligent search of PubMed, Scopus, and Cochrane databases was conducted for pertinent studies until June 2023. The random-effects model was employed to compute pooled odds ratios (ORs) and 95% confidence intervals (CIs), scrutinizing various risk factors like age, gender, lifestyle factors, and common comorbidities.
Results
Our meta-analysis incorporated 21 studies comprising 178,546 participants. We identified significant associations between OSO and factors such as female gender (OR 1.756, 95% CI 1.081 to 2.858), physical inactivity (OR 1.562, 95% CI 1.127–2.165), and hypertension (OR 1.482, 95% CI 1.207–1.821). Conversely, smoking (OR 0.854, 95% CI 0.672–1.084), alcohol consumption (OR 0.703, 95% CI 0.372–1.328), and dyslipidemia (OR 1.345, 95% CI 0.982–1.841) showed no significant associations. Remarkable heterogeneity was observed across studies, indicating considerable variation in effect sizes. Notably, OSO was strongly associated with frailty (OR 6.091; 95% CI 3.576–10.375).
Conclusions
Our study underscored the substantial role of female gender, physical inactivity, and hypertension in the development of OSO, whilst suggesting a strong link between OSO and frailty. These findings emphasize the importance of early risk factor identification and targeted interventions in these groups. Further research is warranted to decode the complex pathophysiological interplay and devise effective prevention and management strategies.
Similar content being viewed by others
References
JafariNasabian P, Inglis JE, Kelly OJ, Ilich JZ (2017) Osteosarcopenic obesity in women: impact, prevalence, and management challenges. Int J Womens Health 9:33–42. https://doi.org/10.2147/IJWH.S106107
Liu Y, Song Y, Hao Q, Wu J (2023) Global prevalence of osteosarcopenic obesity amongst middle aged and older adults: a systematic review and meta-analysis. Arch Osteoporos 18(1):60. https://doi.org/10.1007/s11657-023-01247-5
Ormsbee MJ, Prado CM, Ilich JZ et al (2014) Osteosarcopenic obesity: the role of bone, muscle, and fat on health. J Cachexia Sarcopenia Muscle 5(3):183–192. https://doi.org/10.1007/s13539-014-0146-x
Reginster JY, Beaudart C, Buckinx F, Bruyère O (2016) Osteoporosis and sarcopenia: two diseases or one? Curr Opin Clin Nutr Metab Care 19(1):31–36. https://doi.org/10.1097/MCO.0000000000000230
Fuster JJ, Ouchi N, Gokce N, Walsh K (2016) Obesity-induced changes in adipose tissue microenvironment and their impact on cardiovascular disease. Circ Res 118(11):1786–1807. https://doi.org/10.1161/CIRCRESAHA.115.306885
Bauer JM, Cruz-Jentoft AJ, Fielding RA et al (2019) Is There enough evidence for osteosarcopenic obesity as a distinct entity? A critical literature review. Calcif Tissue Int 105:109–124. https://doi.org/10.1007/s00223-019-00561-w
Ilich JZ, Kelly OJ, Inglis JE, Panton LB, Duque G, Ormsbee MJ (2014) Interrelationship among muscle, fat, and bone: connecting the dots on cellular, hormonal, and whole body levels. Ageing Res Rev 15:51–60
Daskalopoulou C, Wu YT, Pan W et al (2020) Factors related with sarcopenia and sarcopenic obesity among low- and middle-income settings: the 10/66 DRG study. Sci Rep 10:20453. https://doi.org/10.1038/s41598-020-76575-4
Fini M, Salamanna F, Veronesi F et al (2012) Role of obesity, alcohol and smoking on bone health. Front Biosci (Elite Ed) 4(7):2586–2606. https://doi.org/10.2741/e575
Tarantino U, Cariati I, Greggi C, Gasbarra E, Belluati A, Ciolli L, Maccauro G, Momoli A, Ripanti S, Falez F, Brandi ML (2021) Skeletal system biology and smoke damage: from basic science to medical clinic. Int J Mol Sci 22(12):6629. https://doi.org/10.3390/ijms22126629
Traversy G, Chaput JP (2015) Alcohol consumption and obesity: an update. Curr Obes Rep 4(1):122–130. https://doi.org/10.1007/s13679-014-0129-4
Park JH, Moon JH, Kim HJ, Kong MH, Oh YH (2020) Sedentary lifestyle: overview of updated evidence of potential health risks. Korean J Fam Med 41(6):365–373. https://doi.org/10.4082/kjfm.20.0165
Klop B, Elte JW, Cabezas MC (2013) Dyslipidemia in obesity: mechanisms and potential targets. Nutrients 5(4):1218–1240. https://doi.org/10.3390/nu5041218
Díaz ME (2002) Hypertension and obesity. J Hum Hypertens 16(Suppl 1):S18–S22. https://doi.org/10.1038/sj.jhh.1001335
Kobylińska M, Antosik K, Decyk A, Kurowska K (2022) Malnutrition in obesity: Is it possible? Obes Facts 15(1):19–25. https://doi.org/10.1159/000519503
Szlejf C, Parra-Rodríguez L, Rosas-Carrasco O (2017) Osteosarcopenic obesity: prevalence and relation with frailty and physical performance in middle-aged and older women. J Am Med Dir Assoc 18(8):733.e1-733.e5. https://doi.org/10.1016/j.jamda.2017.02.023
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg 1(88):105906
Lo CK, Mertz D, Loeb M (2014) Newcastle-Ottawa Scale: comparing reviewers’ to authors’ assessments. BMC Med Res Methodol 14:1–5
Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (eds) (2019) Cochrane handbook for systematic reviews of interventions. Wiley
Kashiwagi K, Takayama M, Ichikawa H, Takaishi H, Iwao Y, Kanai T (2021) A significant association of non-obese non-alcoholic fatty liver disease with osteosarcopenic obesity in females 50 years and older. Clin Nutr ESPEN 42:166–172
Su YH, Chang YM, Kung CY, Sung CK, Foo WS, Wu MH et al (2021) A study of correlations between metabolic syndrome factors and osteosarcopenic adiposity. BMC Endocr Disord 21(1):216
Chen X, Kong C, Yu H, Gong J, Lan L, Zhou L et al (2019) Association between osteosarcopenic obesity and hypertension among four minority populations in China: a cross-sectional study. BMJ Open 9(7):e026818
Chung JH, Hwang HJ, Shin HY, Han CH (2016) Association between sarcopenic obesity and bone mineral density in middle-aged and elderly Korean. Ann Nutr Metab 68(2):77–84
Lim HS, Kim DK, Gil HI, Lee MY, Lee HS, Lee YT et al (2023) Association of pulmonary function with osteosarcopenic obesity in older adults aged over 50 years. Nutrients 15(13):2933
Kim YM, Kim S, Won YJ, Kim SH (2019) Clinical manifestations and factors associated with osteosarcopenic obesity syndrome: a cross-sectional study in Koreans with obesity. Calcif Tissue Int 105(1):77–88
Pang BWJ, Wee SL, Chen KK, Lau LK, Jabbar KA, Seah WT et al (2021) Coexistence of osteoporosis, sarcopenia and obesity in community-dwelling adults – The Yishun Study. Osteoporos Sarcopenia 7(1):17–23
Abidin NZ, Mitra SR (2021) Comparison of anthropometric profile, bone-related parameters, biochemical parameters, functional capacity, and vitamin D status–a study on postmenopausal Malaysian women. Mal J Nutr 27(2):233–246
Abidin NZ, Mitra SR (2021) Determination of cutoff values for the screening of osteosarcopenia in obese postmenopausal women. Kuo YF, editor. Current Gerontology and Geriatrics Research. 1–15
Bae YJ (2020) Fruit intake and osteosarcopenic obesity in Korean postmenopausal women aged 50–64 years. Maturitas 134:41–46
Cvijetić S, Keser I, Boschiero D, Ilich JZ (2023) Osteosarcopenic adiposity and nutritional status in older nursing home residents during the COVID-19 pandemic. Nutrients 15(1):227
Nie Y-z, Yan Z-q, Yin H, Shan L-h, Wang J-h, Wu Q-h (2022) Osteosarcopenic obesity and its components—osteoporosis, sarcopenia, and obesity—are associated with blood cell count-derived inflammation indices in older Chinese people. BMC Geriatr 22(1):532
Mo D, Hsieh P, Yu H, Zhou L, Gong J, Xu L et al (2018) Osteosarcopenic obesity and its relationship with dyslipidemia in women from different ethnic groups of China. Arch Osteoporos 13(1):65
Ma Y, Zhang W, Han P, Kohzuki M, Guo Q (2020) Osteosarcopenic obesity associated with poor physical performance in the elderly Chinese community. CIA 15:1343–1352
Keramidaki K, Tsagari A, Hiona M, Risvas G (2019) Osteosarcopenic obesity, the coexistence of osteoporosis, sarcopenia and obesity and consequences in the quality of life in older adults ≥365 years-old in Greece. JFSF 1:91–101
Szlejf C, Parra-Rodríguez L, Rosas-Carrasco O (2017) Osteosarcopenic obesity: prevalence and relation with frailty and physical performance in middle-aged and older women. J Am Med Dir Assoc 18(8):733.e1-733.e5
Choi MK, Bae YJ (2020) Protein intake and osteosarcopenic adiposity in Korean adults aged 50 years and older. Osteoporos Int 31(12):2363–2372
Chung SJ, Lim HS, Lee MY, Lee YT, Yoon KJ, Park CH (2022) Sex-specific associations between serum ferritin and osteosarcopenic obesity in adults aged over 50 years. Nutrients 14(19):4023
Sasaki K-i, Kakuma T, Sasaki M, Ishizaki Y, Fukami A, Enomoto M et al (2020) The prevalence of sarcopenia and subtypes in cardiovascular diseases, and a new diagnostic approach. J Cardiol 76(3):266–72
Okyar Baş A, Güner Oytun M, Deniz O, Öztürk Y, Kahyaoğlu Z, Ceylan S et al (2022) Ultrasonografically assessed osteosarcopenic obesity is associated with frailty in community-dwelling older adults. Nutrition 103–104:111827
Kolbaşı EN, Demirdağ F (2020) Prevalence of osteosarcopenic obesity in community-dwelling older adults: a cross-sectional retrospective study. Arch Osteoporos 15:1–9
Yang CY, Cheng-Yen Lai J, Huang WL, Hsu CL, Chen SJ (2021) Effects of sex, tobacco smoking, and alcohol consumption osteoporosis development: Evidence from Taiwan biobank participants. Tob Induc Dis 17(19):52. https://doi.org/10.18332/tid/136419
Zhai J, Ma B, Qin J, Lyu Q, Khatun P, Liang R, Cong M, Guo L, Kong Y (2022) Alcohol consumption patterns and the risk of sarcopenia: a population-based cross-sectional study among chinese women and men from Henan province. BMC Public Health 22(1):1894. https://doi.org/10.1186/s12889-022-14275-6
Manrique C, Lastra G, Gardner M, Sowers JR (2009) The renin angiotensin aldosterone system in hypertension: roles of insulin resistance and oxidative stress. Med Clin North Am 93(3):569–582. https://doi.org/10.1016/j.mcna.2009.02.014
Griendling KK, Camargo LL, Rios FJ, Alves-Lopes R, Montezano AC, Touyz RM (2021) Oxidative stress and hypertension. Circ Res 128(7):993–1020. https://doi.org/10.1161/CIRCRESAHA.121.318063
Marino FR, Lessard DM, Saczynski JS, McManus DD, Silverman-Lloyd LG, Benson CM, Blaha MJ, Waring ME (2019) Gait speed and mood, cognition, and quality of life in older adults with atrial fibrillation. J Am Heart Assoc 8(22):e013212. https://doi.org/10.1161/JAHA.119.013212
Adam CE, Fitzpatrick AL, Leary CS, Hajat A, Phelan EA, Park C, Semmens EO (2021) The association between gait speed and falls in community dwelling older adults with and without mild cognitive impairment. Int J Environ Res Public Health 18(7):3712. https://doi.org/10.3390/ijerph18073712
Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), the Extended Group for EWGSOP2 et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48(1):16–31. https://doi.org/10.1093/ageing/afy169
Funding
National Key Research and Development Program of China, Grant/Award Number: 2018YFC2002100 and 2018YFC2002103.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Ying Liu, Qinjian Hao, Jinqiu Zhou, Jinhui Wu declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Liu, Y., Hao, Q., Zhou, J. et al. A comprehensive meta-analysis of risk factors associated with osteosarcopenic obesity: a closer look at gender, lifestyle and comorbidities. Osteoporos Int 35, 759–773 (2024). https://doi.org/10.1007/s00198-023-07007-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-023-07007-y